What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.24%
Annual Rate
CNY 1.20Paid semi-annual
Payout Ratio
75.1%Moderate
Payback Period
95.4 yr
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
16.01BCNY
2.40B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
87.62x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Revenue (TTM)
1.33BCNY
199.77M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
16.60%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Beta
2.61x
vs all stocks
Updated Oct 24, 2026
52-Week Change
31.74%
vs all stocks
Updated Oct 24, 2026
Forward Annual Dividend Yield
1.24%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
16.01BCNY
2.40B · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
14.39BCNY
2.16B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
87.62x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Forward P/E
27.28x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Price to Sales (TTM)
11.32x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 12.01×.Updated Oct 24, 2026
Price to Book (MRQ)
4.38x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Enterprise to Revenue
10.79x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Enterprise to EBITDA
63.45x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 55.22×.Updated Oct 24, 2026
Gross Margin
46.47%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 44.12%.Updated Oct 24, 2026
Profit Margin
16.60%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Operating Margin
15.96%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Return on Assets (TTM)
2.74%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Return on Equity (TTM)
6.41%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Revenue (TTM)
1.33BCNY
199.77M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
8.14CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
60.80%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Gross Profit (TTM)
588.07MCNY
88.13M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
260.51MCNY
39.04M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
221.27MCNY
33.16M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
76.70%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
176.73MCNY
26.49M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
-179.36MCNY
-26.88M · vs all stocks (USD)
Updated Oct 24, 2026
Forward Annual Dividend Rate
1.20CNYUpdated Oct 24, 2026
Forward Annual Dividend Yield
1.24%
vs all stocks
Updated Oct 24, 2026
Trailing Annual Dividend Rate
1.01CNYUpdated Oct 24, 2026
Trailing Annual Dividend Yield
1.05%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
75.10%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 97.48%.Updated Oct 24, 2026
Minority Interest (Equity)
42.56MCNYFY2025 · Dec 31, 2025
Revenue
1.08BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
600.61MCNYFY2025 · Dec 31, 2025
Gross Profit
477.32MCNYFY2025 · Dec 31, 2025
Operating Income
160.65MCNY
24.08M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
192.15MCNYFY2025 · Dec 31, 2025
Income Tax Expense
18.42MCNYFY2025 · Dec 31, 2025
Net Income
173.73MCNYFY2025 · Dec 31, 2025
EBIT
194.96MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
222.75MCNYFY2025 · Dec 31, 2025
Research & Development
115.80MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
66.39MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
10.04MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
11.60MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.81MCNYFY2025 · Dec 31, 2025
EPS (Basic)
1.07CNYFY2025 · Dec 31, 2025
EPS (Diluted)
1.07CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
164.52MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
164.52MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
173.73MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
2.31MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-12.90MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-346.54MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
309.59MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
173.73MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
8.01MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-157.42MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-37.23MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-333.64MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-89.39MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-5.67BCNYFY2025 · Dec 31, 2025
Sale of Investments
6.09BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-11.02MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-13.24MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
84.95MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-70.58MCNYFY2025 · Dec 31, 2025
Other Financing Charges
23.10MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
37.48MCNYFY2025 · Dec 31, 2025
Shares Outstanding
165.59MSharesUpdated Oct 24, 2026
Float Shares
102.96MSharesUpdated Oct 24, 2026
% Held by Insiders
40.39%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
14.71%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
1.68BCNY
252.00M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
10.21CNYUpdated Oct 24, 2026
Total Debt (MRQ)
204.67MCNY
30.67M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.0582x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Current Ratio (MRQ)
3.19x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
20.82CNYUpdated Oct 24, 2026
Total Assets
4.10BCNY
613.91M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.37BCNYFY2025 · Dec 31, 2025
Total Liabilities
679.76MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.73BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
86.81MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
592.95MCNYFY2025 · Dec 31, 2025
Cash
309.37MCNYFY2025 · Dec 31, 2025
Cash Equivalents
24.94MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
334.31MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.16BCNYFY2025 · Dec 31, 2025
Accounts Receivable
358.37MCNYFY2025 · Dec 31, 2025
Inventory
305.71MCNYFY2025 · Dec 31, 2025
Accounts Payable
326.45MCNYFY2025 · Dec 31, 2025
Short-term Debt
51.69MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
32.71MCNYFY2025 · Dec 31, 2025
Long-term Debt
75.44MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.09MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
165.59MCNYFY2025 · Dec 31, 2025
Retained Earnings
272.89MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.42BCNY
512.03M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
74.12MCNYFY2025 · Dec 31, 2025
52-Week Low
58.50CNYUpdated Oct 24, 2026
52-Week High
215.00CNYUpdated Oct 24, 2026
52-Week Change
31.74%
vs all stocks
Updated Oct 24, 2026
Beta
2.61x
vs all stocks
Updated Oct 24, 2026
50-Day MA
129.97CNYUpdated Oct 24, 2026
200-Day MA
117.50CNYUpdated Oct 24, 2026
Avg 10-Day Volume
3.49MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
3.74MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
1.04CNYUpdated Oct 24, 2026
5 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Down-Close Streak With Profitability
A run of down weeks on a company profitable three years running and funded by equity.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Operating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDown-Close Streak With ProfitabilityMulti-Year Revenue And Profit Growth
Operating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDown-Close Streak With ProfitabilityMulti-Year Revenue And Profit Growth
Operating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDown-Close Streak With ProfitabilityMulti-Year Revenue And Profit Growth